Inflammation may have a pathogenic role in the progression of nonalcoholic fatty liver disease (NAFLD); by contrast, the role of anti-inflammatory molecules has not been addressed. Low circulating levels of the anti-inflammatory molecule IGF-I have been described in subjects with NAFLD.
|Numero di pagine||5|
|Rivista||THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM|
|Stato di pubblicazione||Published - 2013|
All Science Journal Classification (ASJC) codes
- Endocrinology, Diabetes and Metabolism
- Clinical Biochemistry
- Biochemistry, medical